When people think of pharmaceutical hubs, they usually think of Boston, San Francisco, or New Jersey. But Texas is quietly—and rapidly—disrupting the entire domestic bio-manufacturing landscape.

From specialized cell therapies to high-purity plasmid DNA and massive large-molecule plants, the Lone Star State is experiencing an unprecedented infrastructure wave.
Here is a breakdown of the top 10 CDMOs driving this transformation across the state, categorized by their technical capabilities:

💡NACDS Total Store Expo, Boston 2026

We are excited to announce that Quality CDMO will be attending NACDS Total Store Expo, Boston 2026 connecting with leading retailers, brands, and industry professionals.

Visit us at booth No 2115 to explore our OTC pharmaceutical manufacturing, product development, formulation, and packaging capabilities and discuss how we can support your next product opportunity.

💡FDA Zero Inspection Observations

Quality CDMO has successfully completed an FDA inspection with zero observations issued, reflecting the strength of our quality systems and commitment to cGMP compliance.

Our quality culture is supported by robust procedures, comprehensive documentation, effective controls, and continuous improvement.

🧬 The Biologics, Cell, & Gene Therapy Powerhouses:

FUJIFILM Diosynth Biotechnologies (College Station): A global giant managing large-scale biologics, viral vectors, and vaccines. VGXI, Inc. (The Woodlands/Conroe): An industry-renowned pioneer specializing in high-purity plasmid DNA. Cellipont Bioservices (The Woodlands): A specialized cell therapy partner that just hit a massive milestone of releasing its 100th GMP batch.

CTMC (Houston): A powerhouse joint venture between Resilience and MD Anderson Cancer Center accelerating academic innovation into clinical manufacturing. Matica Biotechnology (College Station): Built explicitly for the agile, fast-paced development of viral vectors. Scorpius BioManufacturing (San Antonio): Providing modular solutions for mammalian and microbial cGMP clinical production.

🧴 The Small Molecule, Topical, & OTC Market Leaders:

DPT Laboratories (San Antonio): Boasting an 80-year legacy, they are the definitive domestic leader for semi-solid and liquid dosage forms. LGM Pharma (Rosenberg): Integrating global API sourcing with downstream production, backed by a recent $15M multi-facility expansion. Quality CDMO (Fort Worth):

Operating a modern, flexible 44k sq. ft. facility focused on quick-turn OTC liquids, gels, and suppositories. Sovereign Pharmaceuticals (Fort Worth): A trusted partner for 30+ years handling formulation development and high-speed packaging for oral solid doses.

💡 The Big Picture:

The momentum isn’t slowing down. Major players like Bristol Myers Squibb are doubling down on the region, recently announcing a massive $2.3 Billion modular, multi-modal campus in Houston to handle everything from biologics to antibody-drug conjugates (ADCs). Whether you are looking for advanced therapy scaling in the Houston corridor or agile liquid formulation in DFW, Texas has built a highly integrated ecosystem ready for the future of medicine.